| Bioactivity | Luteolin-7-rutinoside has both anti-arthritic and antifungal activities, can result in a combination therapy for the treatment of fungal arthritis due to C. albicans infection. | ||||||||||||
| Invitro | At a dose of 10 μg Luteolin-7-rutinoside (lonicerin)/mL, there is an approximately 47% decrease of the proliferation as compared to proliferation of Luteolin-7-rutinoside treated (control) T cells (p<0.05). Luteolin-7-rutinoside at 40 μg/mL dose give almost the same rate of T cell proliferation as does 20 μg/mL dose of Luteolin-7-rutinoside. The suppressive activity is dose dependent. Luteolin-7-rutinoside treatment swifts Th1-Th2 balance away from Th1-toward Th2-type responses. Luteolin-7-rutinoside inhibits nitric oxide (NO) production from macrophages[1]. | ||||||||||||
| Name | Luteolin-7-rutinoside | ||||||||||||
| CAS | 20633-84-5 | ||||||||||||
| Formula | C27H30O15 | ||||||||||||
| Molar Mass | 594.52 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Luteolin-7-rutinoside
CAS: 20633-84-5 F: C27H30O15 W: 594.52
Luteolin-7-rutinoside has both anti-arthritic and antifungal activities, can result in a combination therapy for the tre
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.